Cardiologs Technologies announced today that it has raised $6.4 million in a Series A financing from new investors Idinvest, ISAI, Kurma Partners, and Partech Ventures, as well as current investor Bpifrance seed fund (F3A).
In July, 2017, Cardiologs announced FDA clearance of its Cardiologs ECG analysis platform, an ECG- analysis web solution powered by artificial intelligence. Cardiologs assists physicians in screening for 10 arrhythmias, including atrial fibrillation, using ambulatory ECG monitoring recordings.
The Cardiologs solution has been approved to detect up to 100 cardiac abnormalities in Europe. Currently, the detection of 10 significant arrhythmias is available in the United States, covering most clinical cases of ambulatory ECG monitoring. The company plans to extend its AI capacity beyond ECG diagnostics claims.